# Ybrain

Startup profile on Capital Atlas: https://capitalatlas.ai/startups/ybrain

- Industry: Medical Devices & Equipment
- Headquarters: Seoul, South Korea
- Website: www.ybrain.com
- Total disclosed funding: $13M
- Latest round: Series C (Jan 29, 2020)
- Investors on record: 7

## About

Based in Seongnam, South Korea, and founded in 2013 by Kiwon Lee, Waibrain Co., Ltd., d.b.a. Ybrain develops electronic devices using micro-electrical stimulation technology for the treatment of various brain diseases, such as dementia and depression. In February 2022, Ybrain raised KRW 11 billion in pre-IPO funding from CERAGEM, InterVest, and KT&G Corporation. As of February 2022, the company has raised a total of USD 9.23 million in funding.

Ybrain’s team of neuroscience, software, and hardware talents provide a wide range of product lines, including scan, doopang, stim, and pola. The scan is EEG diagnostic medical device while doopang is migraine treatment medical device. The stim is a food and drug administration licensed depression treatment medical device while pola is a mind and body stability, stress-relieving device. The company also provide mindd, a mental health care integration platform that offers scale inspection and smart management solution for sending and implementing scale inspections and their results.

The company plans to use its proceeds from pre-IPO funding to acquire FDA approval and its additional indications and complete the technical evaluation on its technology.

## Funding rounds

- Series C, Jan 29, 2020, $5.5M — STIC Investments, G.N.TECH Venture Capital, DT&Investment, Neofect Co., Ltd
- Series B, Sep 1, 2015, $3.4M — DSC Investment
- Series A, Aug 28, 2014, $3.4M — Company K Partners
- Seed, Feb 14, 2013, $0.6M — Solborn Venture Investment

## Investors

- Solborn Venture Investment (https://capitalatlas.ai/funds/solborn-venture-investment) — Seed
- Company K Partners (https://capitalatlas.ai/funds/company-k-partners) — Series A
- DSC Investment (https://capitalatlas.ai/funds/dsc-investment) — Series B
- STIC Investments (https://capitalatlas.ai/funds/stic-investments) — Series C
- G.N.TECH Venture Capital (https://capitalatlas.ai/funds/g-n-tech-venture-capital) — Series C
- DT&Investment (https://capitalatlas.ai/funds/dt-investment) — Series C
- Neofect Co., Ltd — Series C